Vaxgen has reported a low overall success rate for its vaccine, Aidsvax, in a study designed to test how well the vaccine prevents HIV infection. Black and Asian sub-groups, however, showed a better response that the study population as a whole. The reduction of infection among the entire sample of volunteers, including all racial groups, was just under 4 per cent-not statistically significant.
展开▼
